Literature DB >> 18211414

No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus.

C Bascones-Ilundain1, M A González-Moles, J Campo-Trapero, J A Gil-Montoya, G C Esparza-Gómez, J Cano-Sánchez, A Bascones-Martínez.   

Abstract

BACKGROUND: Caspase-3 (CPP32) and Bax expression levels in oral lichen planus (OLP) lesions are considered reliable markers of apoptosis. The malignant transformation of OLP remains a very controversial matter. The objective of this study was to compare histological and apoptotic phenomena between atrophic-erosive and reticular forms of OLP.
METHODS: Analysis was conducted of biopsy samples from 18 patients with reticular and 14 with atrophic-erosive OLP. Conventional histology techniques were used to quantify histological markers of OLP and peroxidase/anti-peroxidase techniques to determine apoptosis markers caspase-3 (CPP32) and Bax.
RESULTS: More Civatte bodies and lymphocyte exocytosis were observed in atrophic-erosive than reticular OLP samples, without any statistical difference. No statistical significant differences in caspase-3 expression were found between these OLP forms in suprabasal layer (58.3% vs. 43.8%), basal layer (83.3% vs. 68.8%) or infiltrate (69.2% vs. 46.6%). Bax expression was relatively infrequent, and no differences were observed between atrophic-erosive and reticular forms.
CONCLUSIONS: The low frequency of apoptotic phenomena (caspase-3 and Bax) in epithelial cells of OLP may create a favourable substrate for malignant transformation. However, there does not seem to be an association with the clinical form (atrophic-erosive or reticular).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211414     DOI: 10.1111/j.1468-3083.2007.02387.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Immunohistochemical Expression of Caspase-3 in Psoriasis.

Authors:  Shaimaa M M Bebars; Dalia Rifaat Al-Sharaky; Mohammed A Gaber; Dina Ragab Afify
Journal:  J Clin Diagn Res       Date:  2017-07-01

2.  Down-regulation of miRNA-27b-3p suppresses keratinocytes apoptosis in oral lichen planus.

Authors:  Junjun Chen; Yufeng Wang; Guanhuan Du; Wenyi Zhang; Tianyi Cao; Linjun Shi; Yanni Wang; Jun Mi; Guoyao Tang
Journal:  J Cell Mol Med       Date:  2019-04-11       Impact factor: 5.310

Review 3.  Probiotics as Potential Biological Immunomodulators in the Management of Oral Lichen Planus: What's New?

Authors:  Paola Zanetta; Margherita Ormelli; Angela Amoruso; Marco Pane; Barbara Azzimonti; Diletta Francesca Squarzanti
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 4.  Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Fábio França Vieira E Silva; María Elena Padín-Iruegas; Vito Carlo Alberto Caponio; Alejandro I Lorenzo-Pouso; Paula Saavedra-Nieves; Cintia Micaela Chamorro-Petronacci; José Suaréz-Peñaranda; Mario Pérez-Sayáns
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

5.  Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.

Authors:  Shima Nafarzadeh; Sina Jafari; Ali Bijani
Journal:  Int J Mol Cell Med       Date:  2013

Review 6.  Molecular markers in oral lichen planus: A systematic review.

Authors:  Shitalkumar Sagari; Sudhanshu Sanadhya; Mallikarjun Doddamani; Rajan Rajput
Journal:  J Oral Maxillofac Pathol       Date:  2016 Jan-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.